Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents

Haploidentical Hematopoietic Stem Cell Transplantation Clinical Trial

Official title:
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents

Status Recruiting

Clinical Trial Summary

Purpose of study: This phase I/II trial is to evaluate the safety and feasibility of TCRαβ-depleted graft from haploidentical family donors in treating children and adolescents with malignant or non-malignant diseases.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Haploidentical Hematopoietic Stem Cell Transplantation
Malignant Disease
Non-malignant Disease

Clinical Trial Details

NCT number	NCT02014506
Study type	Interventional
Source	Asan Medical Center
Contact	Ho Joon Im, MD, PhD
Phone	82-2-3010-3371
Email	hojim@amc.seoul.kr
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	January 2017
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00881166` - Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors	Phase 1
Completed	`NCT02447237` - Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients	N/A
Recruiting	`NCT05437328` - GD2/CD56 Bi-specific CAR-T Cell Therapy	Phase 1/Phase 2
Recruiting	`NCT03580109` - Spa Therapy for Upper or Lower Limb Lymphoedema	N/A
Active, not recruiting	`NCT03560882` - A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies	Phase 1
Terminated	`NCT03995927` - Palliative Radiation Oncology Chief's Clinic